12:00 AM
 | 
Apr 11, 2011
 |  BC Week In Review  |  Company News  |  Deals

Inovio, OncoSec deal

OncoSec Medical completed its previously announced acquisition of Inovio's selective electrochemical tumor ablation (SECTA) technology. The deal also...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >